Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CARA

Cara Therapeutics (CARA)

Cara Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CARA
DateTimeSourceHeadlineSymbolCompany
08/03/20178:00AMGlobeNewswire Inc.Cara Therapeutics to Webcast Presentation at the Canaccord Genuity 37th Annual Growth ConferenceNASDAQ:CARACara Therapeutics Inc
08/01/20177:00AMGlobeNewswire Inc.Cara Therapeutics Appoints Mani Mohindru, Ph.D., Chief Financial OfficerNASDAQ:CARACara Therapeutics Inc
07/28/20174:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CARACara Therapeutics Inc
07/27/20174:30PMGlobeNewswire Inc.Cara Therapeutics to Announce Second Quarter 2017 Financial Results on August 3, 2017NASDAQ:CARACara Therapeutics Inc
07/25/20178:45AMInvestorWirePotential Blockbuster Treatment for Alzheimer’s Disease Stands Out Among Medical Cannabis CompaniesNASDAQ:CARACara Therapeutics Inc
07/18/20176:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CARACara Therapeutics Inc
07/18/20176:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CARACara Therapeutics Inc
07/12/20177:00AMGlobeNewswire Inc.Cara Therapeutics Announces Summary Data From Phase 1 Trial of Oral CR845 in Hemodialysis Patients with Chronic Kidney Diseas...NASDAQ:CARACara Therapeutics Inc
07/11/201711:08AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CARACara Therapeutics Inc
07/03/20175:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CARACara Therapeutics Inc
06/29/20174:01PMGlobeNewswire Inc.Cara Therapeutics Announces Top-line Results From Phase 2b Trial of Oral CR845 in Chronic Pain Patients With Osteoarthritis o...NASDAQ:CARACara Therapeutics Inc
06/23/20176:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CARACara Therapeutics Inc
06/23/20176:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CARACara Therapeutics Inc
06/23/20176:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CARACara Therapeutics Inc
06/23/20176:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CARACara Therapeutics Inc
06/23/20177:00AMGlobeNewswire Inc.Cara Receives Breakthrough Therapy Designation from FDA for I.V. CR845 for the Treatment of Chronic Kidney Disease-Associated...NASDAQ:CARACara Therapeutics Inc
06/22/20174:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CARACara Therapeutics Inc
06/21/20177:00AMGlobeNewswire Inc.Cara Therapeutics Reports Continuation of Phase 3 Trial of I.V. CR845 in Postoperative Pain Following Interim AssessmentNASDAQ:CARACara Therapeutics Inc
05/17/20178:45AMInvestorWireCannabis-Based Therapies with Potential to Dull the Pain of Opioid AbuseNASDAQ:CARACara Therapeutics Inc
05/17/20178:00AMGlobeNewswire Inc.Cara Therapeutics to Present at the 17th Annual Conference on Pain TherapeuticsNASDAQ:CARACara Therapeutics Inc
05/12/20174:01PMGlobeNewswire Inc.Cara Therapeutics to Host KOL Meeting on Chronic Kidney Disease-Associated Pruritus on May 16, 2017NASDAQ:CARACara Therapeutics Inc
05/11/20174:48PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CARACara Therapeutics Inc
05/10/20174:10PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CARACara Therapeutics Inc
05/10/20174:07PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CARACara Therapeutics Inc
05/09/201710:18AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CARACara Therapeutics Inc
05/04/20175:30PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CARACara Therapeutics Inc
05/04/20174:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CARACara Therapeutics Inc
05/04/20174:01PMGlobeNewswire Inc.Cara Therapeutics Reports First Quarter 2017 Financial ResultsNASDAQ:CARACara Therapeutics Inc
04/27/20178:00AMGlobeNewswire Inc.Cara Therapeutics to Announce First Quarter 2017 Financial Results on May 4, 2017NASDAQ:CARACara Therapeutics Inc
04/24/20177:00AMGlobeNewswire Inc.Cara Therapeutics Announces Positive Data From Quantitative Phase 1 Trial Measuring Respiratory Safety of I.V. CR845NASDAQ:CARACara Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CARA